Biotest Ag

Daniele Wolf

Benjamin Daelken

Frank Osterroth

Christoph Bruecher

Christoph Uherek

Matthias Germer

Andrea Wartenberg-Demand

Silke Aigner

Elmar Kraus

Sibylle Kaiser

Juergen Lindner

Gregor Schulz

The present invention provides pharmaceutical composition for treating an autoimmune disease comprising a pharmaceutically acceptable carrier and an agent capable of activating CD4+CD25+ regulatory T cells, wherein the composition is to be administered to a subject at most every 3 days.

Method for treating psoriasis

The present invention provides a pharmaceutical composition for treating an autoimmune disease comprising a pharmaceutically acceptable carrier and an agent capable of activating CD4+CD25+ regulatory T cells, wherein the composition is to be administered to a subject in a dose of the agent from 10 mg to 200 mg.

Agent for treating disease

The present invention provides a pharmaceutical composition for treating an autoimmune disease comprising a pharmaceutically acceptable carrier and an agent capable of activating CD4+CD25+ regulatory T cells, wherein the composition is to be administered to a subject in a dose of the agent from 0.2 mg to 30 mg.

Growing community of inventors

Dreieich, Germany

Daniele Wolf